Contact information
Type
Scientific
Primary contact
Dr J.E. Jacobs
ORCID ID
Contact details
University Medical Center St Radboud
Center for Quality of Care Research (WOK)
P.O. Box 9101
Nijmegen
6500 HB
Netherlands
+31 (0)24 3615310
j.jacobs@kwazo.umcn.nl
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
NTR614
Study information
Scientific title
Acronym
TAPS
Study hypothesis
The intervention increases advice given by dental professionals, the number of patients having quit smoking and the number of quit attempts.
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Other
Trial type
Treatment
Patient information sheet
Condition
Tobacco addiction
Intervention
Provision of a 4 hour central course for whole practice teams, patient-mediated monitoring and feedback of the provision of cessation advice, patient education materials and a task organisation protocol for the various members of the dental team.
The dental teams in the control group deliver usual care.
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measures
Patient-reported number of smoking cessation advice given by the dental team, patients' smoking status and quit attempts.
Secondary outcome measures
Professionals' attitudes towards smoking and smoking cessation support, their knowledge of health consequences of smoking tobacco (especially dental health), patients' perspectives of smoking cessation.
Support by dentists will be measured as well as self-efficacy to provide smoking cessation support.
Overall trial start date
01/01/2006
Overall trial end date
01/11/2008
Reason abandoned
Eligibility
Participant inclusion criteria
Smoking patients visiting dental practices.
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
1300
Participant exclusion criteria
Patients under the age of 18.
Recruitment start date
01/01/2006
Recruitment end date
01/11/2008
Locations
Countries of recruitment
Netherlands
Trial participating centre
University Medical Center St Radboud
Nijmegen
6500 HB
Netherlands
Funders
Funder type
Industry
Funder name
Pfizer (Netherlands)
Alternative name(s)
Pfizer Inc.
Funding Body Type
private sector organisation
Funding Body Subtype
corporate
Location
United States of America
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary